by Kevin Dooley, MD | Dec 5, 2018 | News and Information
In sporadic inclusion body myositis (sIBM), which comes first: inflammation or degeneration? Dr. Christopher Lindberg and his team of researchers in Sweden recently attempted to answer this question. Both of these disease processes are present in the muscles in IBM,...
by Kevin Dooley, MD | Dec 8, 2017 | News and Information
From the soil of Easter Island to the clinics of Paris, the journey of rapamycin to its current position as a potential treatment for sporadic inclusion body myositis is a fascinating story of scientific discovery. A recent clinical trial provided encouraging results,...
